Immunomodulatory effects of azithromycin on serum amyloid A production in lipopolysaccharide-induced endotoxemia in mice

Journal of Antibiotics

Volumn 64, Issue 7, 2011, Pages 515-517

  Tkalčević, Vanesa Ivetić ^a   Hrvačić, Boška ^a   Pašalić, Ivanka ^a   Haber, Vesna Eraković ^a   Glojnarić, Ines ^a  

^a Galapagos Istraživač ki centar doo ^*  (Croatia)

Author keywords

azithromycin anti inflammatory activity; azithromycin immunomodulation; endotoxemia; IL 6; LPS; serum amyloid A

Indexed keywords

AZITHROMYCIN; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; SERUM AMYLOID A;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; DRUG MECHANISM; ENDOTOXEMIA; IMMUNOMODULATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTI-INFLAMMATORY AGENTS; AZITHROMYCIN; BLOOD CELL COUNT; ENDOTOXEMIA; INFLAMMATION; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MALE; MICE; MICE, INBRED BALB C; SERUM AMYLOID A PROTEIN;

MUS;

EID: 79960946872     PISSN: 00218820     EISSN: 18811469     Source Type: Journal    
DOI: 10.1038/ja.2011.14     Document Type: Article

References (14)

1. Amsden, G. W. Anti-inflammatory effects of macrolides-an underappreciated benefit in the treatment of the community acquired respiratory tract infections and chronic inflammatory pulmonary conditions? J. Antimicrob. Chemother. 55, 10-21 (2005). (Pubitemid 40192609)
2. Ç ulić, O., Eraković , V. ́ Parnham, M. J. Anti-inflammatory effects of macrolide antibiotics. Eur. J. Pharmacol. 429, 209-229 (2001). (Pubitemid 33043997)
3. Ivetić Tkalçević, V. et al. Anti-inflammatory activity of azithromycin attenuates the effects of lipopolysaccharide administration in mice. Eur. J. Pharmacol. 539, 131-138 (2006). (Pubitemid 44208808)
4. Ivetić Tkalçević, V. et al. The anti-inflammatory activity of clarithromycin inhibits TNFa production and prolongs survival following lipopolysaccharide administration in mice. Int. J. Antimicrob. Agents 32, 195-196 (2008).
5. Leiva, M., Ruiz-Bravo, A., Moreno, E. ́ Jimenez-Valera, M. The anti-inflammatory activity of telithromycin in a mouse model of septic shock. Int. J. Antimicrob. Agents 29, 364-365 (2007). (Pubitemid 46240751)
6. Shapiro, L. ́ Gelfand, J. A. Cytokines and sepsis: pathophysiology and therapy. N. Horiz. 1, 13-22 (1993).
7. Gabay, C. ́ Kushner, I. Acute-phase proteins and other systemic responses to inflammation. N. Engl. J. Med. 340, 448-454 (1999). (Pubitemid 29084777)
8. Uhlar, C. M. ́ Whitehead, A. S. Serum amyloid A, the major vertebrate acute-phase reactant. Eur. J. Biochem. 265, 501-523 (1999). (Pubitemid 29488982)
9. Copeland, S., Warren, H. S., Lowry, S. F., Calvano, S. E. ́ Remick, D. Acute inflammatory response to endotoxin in mice and humans. Clin. Diagn. Lab. Immunol. 12, 60-67 (2005).
10. Bone, R. C. Toward a theory regarding the pathogenesis of the systemic inflammatory response syndrome: what we do and do not know about cytokine regulation. Crit. Care Med. 24, 163-172 (1996).
11. Schultz, M. J. Macrolide activities beyond their antimicrobial effects: macrolides in diffuse panbronchiolitis and cystic fibrosis. J. Antimicrob. Chemother. 54, 21-28 (2004). (Pubitemid 39028963)
12. Gorrini, M. et al. Inhibition of human neutrophil elastase by erythromycin and flurythromycin, two macrolide antibiotics. Am. J. Respir. Cell. Mol. Biol. 25, 492-499 (2001). (Pubitemid 33037682)
13. Bailly, S., Pocidalo, J. J., Fay, M. ́ Gougerot-Poicidalo, M. A. Differential modulation of cytokine production by macrolides: interleukin-6 production is increased by spiramycin and erythromycin. Antimicrob. Agents Chemother. 35, 2016-2019 (1991).
14. Khan, A. A., Silfer, T. R., Araujo, G. ́ Remington, J. S. Effects of clarithromycin and azithromycin on production of cytokines by human monocytes. Int. J. Antimicrob. Agents 11, 121-132 (1999). (Pubitemid 29114971)